UDR (NYSE:UDR – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided EPS guidance of 2.120-2.240 for the period, compared to the consensus EPS estimate of 2.440. The company issued revenue guidance of -. UDR also updated its FY24 guidance to $2.38-$2.50 EPS.
UDR Price Performance
Shares of UDR stock traded down $0.21 during trading hours on Tuesday, reaching $38.08. The stock had a trading volume of 3,263,255 shares, compared to its average volume of 2,946,120. The stock’s 50 day moving average is $36.82 and its 200 day moving average is $35.98. The firm has a market capitalization of $12.54 billion, a PE ratio of 28.42, a PEG ratio of 3.03 and a beta of 0.80. UDR has a twelve month low of $30.95 and a twelve month high of $44.02. The company has a current ratio of 5.15, a quick ratio of 5.15 and a debt-to-equity ratio of 1.47.
UDR Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 30th. Shareholders of record on Wednesday, April 10th will be given a $0.425 dividend. The ex-dividend date is Tuesday, April 9th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 4.46%. This is an increase from UDR’s previous quarterly dividend of $0.42. UDR’s dividend payout ratio is 126.87%.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on UDR
About UDR
UDR, Inc (NYSE: UDR), an S&P 500 company, is a leading multifamily real estate investment trust with a demonstrated performance history of delivering superior and dependable returns by successfully managing, buying, selling, developing and redeveloping attractive real estate communities in targeted U.S.
See Also
- Five stocks we like better than UDR
- The Role Economic Reports Play in a Successful Investment Strategy
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Insider Trades May Not Tell You What You Think
- Hilton Demonstrates Asset Light is Right for Investors
- Canada Bond Market Holiday: How to Invest and Trade
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for UDR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDR and related companies with MarketBeat.com's FREE daily email newsletter.